Drug-Target Affinity Prediction via Topological Graphs

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current drug design methods struggle to accurately predict the affinity between a drug and its target, which is crucial for effective drug development and discovery.

Innovation Solution

The proposed solution involves using persistent spectral graph (PerSpect) theory to predict drug-target affinity by computing topological structure graphs that label spatial characteristics of atoms in a compound, and then applying these graphs to a deep learning model for affinity determination.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional molecular representation methods (feature engineering or standard neural networks) are used, then the drug design process is straightforward, but the prediction accuracy of drug-target affinity is insufficient

Engineering Contradiction:
Improveprediction accuracy of drug-target affinityVSAvoidcomplexity of molecular representation method
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent transforms molecular data from traditional formats into topological structure graphs, changing the parameter representation from conventional molecular descriptors to graph-based topological features. This transformation enables the deep learning model to capture spatial relationships and structural characteristics more effectively, thereby improving prediction accuracy while maintaining manageable complexity through systematic graph construction protocols

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If complex deep learning models are applied to improve prediction accuracy, then affinity prediction becomes more precise, but the computational complexity and difficulty of implementation increase

Engineering Contradiction:
Improveaffinity prediction precisionVSAvoiddifficulty of implementing prediction model
Core Design Contradiction:
Measurement precisionVSDifficulty of detecting and measuring

Solution Approach 1:

The patent segments the drug-target interaction system into distinct topological components (drug molecule graph, target molecule graph, and their interaction graph). Each component is processed independently to extract topological features, which are then integrated for affinity prediction. This segmentation simplifies the implementation complexity by breaking down the complex deep learning task into manageable modular steps while maintaining high prediction precision

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS12334193B2Method and system for predicting affinity between drug and target
Publication Date: 2025.06.17 ALIBABA (CHINA) CO LTD
  • US12334193B2 patent drawing
  • US12334193B2 patent drawing
  • US12334193B2 patent drawing

AI summary

Prediction of an affinity between a drug and a target is disclosed. The drug and the target for interacting with the drug are acquired. An interaction is caused between the drug and the target to determine the compound. Topological structure graphs for labeling spatial characteristics of atoms in the compound are computed. An affinity between the drug and the target based on the topological structure graphs is determined.